Clinical Impacts of Omalizumab on the Psychiatric Comorbidities of Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis

J Drugs Dermatol. 2024 Apr 1;23(4):e116-e117. doi: 10.36849/JDD.7919.

Abstract

Individuals with chronic spontaneous urticaria (CSU) experience significant sleep disturbances and are at risk of anxiety and depression.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Editorial

MeSH terms

  • Anti-Allergic Agents* / therapeutic use
  • Chronic Disease
  • Chronic Urticaria* / drug therapy
  • Humans
  • Omalizumab / therapeutic use
  • Treatment Outcome
  • Urticaria* / drug therapy
  • Urticaria* / epidemiology

Substances

  • Omalizumab
  • Anti-Allergic Agents